|
Comparison between 2 different groups of patients with allergy to common wasp according to reaction to sting after cessation of it |
||||||
| A N = 50 |
B N = 17 |
p values |
||||
|
|
||||||
| No. |
% |
No |
% |
|||
|
|
||||||
| Age |
≤ 29 |
10 |
20 |
1 |
6 |
0.434 |
| 30–59 |
34 |
68 |
14 |
82 |
||
| ≥ 60 |
6 |
12 |
2 |
12 |
||
| Gender |
Male |
33 |
66 |
9 |
53 |
0.391 |
| Female |
17 |
34 |
8 |
47 |
||
| Inclusion symptom |
Vascular |
20 |
40 |
6 |
35 |
0.731 |
| Respiratory |
13 |
26 |
3 |
17 |
0.485 |
|
| Inclusion symptom |
Vascular + respiratory |
16 |
32 |
8 |
47 |
0.38 |
| SPT pos. inhalation allergens |
15 |
30 |
6 |
35 |
0.684 |
|
| Reaction to rush regimen |
No / local swelling |
29 |
58 |
7 |
41 |
0.020 |
| SAR |
4 |
8 |
6 |
35 |
0.013 |
|
| Pos. SPT to venom 5 th year |
16 |
32 |
9 |
53 |
0.123 |
|
| Venom RAST, pos. 5 th year |
26/48 |
54 |
11/14 |
79 |
0.129 |
|
| Total IgE ≥ 123, 5 th year |
9/44 |
20 |
6/14 |
43 |
0.158 |
|
| Duration of IT in years |
7.1 (5–15) |
6.5 (5–10) |
0.156 |
|||
|
A: Patients allergic to common wasp who have had a minimum of 5 years of immunotherapy at full dose and have not had any reaction to subsequent stings. B: Patients allergic to common wasp, who have had at least 5 years of immunotherapy at full dose, but after cessation have had serious reactions to stings. | ||||||
Haye and Døsen Clinical and Molecular Allergy 2005 3:12 doi:10.1186/1476-7961-3-12 |
||||||